TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CRVS

Corvus Pharmaceuticals Inc

Healthcare · Biotechnology

12.60$ +0.1% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Corvus Pharmaceuticals Inc (CRVS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · 0.0 % 23 Q4 23 · -16.7 % 23 Q1 24 · 7.7 % 24 Q2 24 · 36.4 % 24 Q3 24 · -400.0 % 24 Q4 24 · -19.1 % 24 Q1 25 · -16.7 % 25 Q2 25 · 23.1 % 25 Q3 25 · 7.7 % 25 Q4 25 · -18.5 % 25 Q1 26 · 0.0 % 26 Q2 26 · -11.8 % 26

EPS estimate beaten

Full history 17 of 42 quarters (40%)
Last 16 quarters 5 of 16 quarters (31%)

Earnings Call Transcripts

Search all transcripts →

  • 08/06/2026 Earnings Call Q2 2026 Open →
  • 03/12/2026 Earnings Call Q4 2025 Open →
  • 11/04/2025 Earnings Call Q3 2025 Open →
  • 08/08/2025 Earnings Call Q2 2025 Open →
  • 05/08/2025 Earnings Call Q1 2025 Open →
  • 03/25/2025 Earnings Call Q4 2024 Open →
  • 11/13/2024 Earnings Call Q3 2024 Open →

News on This Stock

  • 08/06/2026 Corvus Pharmaceuticals, Inc. (CRVS): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/22/2026 Corvus Pharmaceuticals, Inc. (CRVS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?